Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varlitinib plus capecitabine vs placebo plus capecitabine in second-line advanced or metastatic biliary tract cancer
jRCT2080223894Phase 3Completed
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in biliary cancer comparing varlitinib plus capecitabine with placebo plus capecitabine (2 arms). Started May 2018; status: completed.
02
Drugs
varlitinib
03
Conditions
biliary cancer
Beyond the preview
Go deeper on jRCT2080223894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223894.